Submission package RETRO-VASCULAID-AAA clinical DATA study
(s’ouvre dans une nouvelle fenêtre)
Submission package RETRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-AAA clinical DATA study: retrospective data collection of 5000 patients at clinical partners (Annex Clinical Studies).
Protocol and SOPs for collection of data for each data type
(s’ouvre dans une nouvelle fenêtre)
Protocol and SOPs for collection of data (medical images and pathological analysis) for each data type
A functional design describing the architecture and data flows that will be forming the apps
(s’ouvre dans une nouvelle fenêtre)
A functional design describing the architectureand data flows that will be forming the apps will be delivered.
Submission package PRO-VASCULAID-AAA clinical DATA study
(s’ouvre dans une nouvelle fenêtre)
Submission package PRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-AAA clinical DATA study: prospective data collection of 350 patients (phase I) at clinical partners (Annex Clinical Studies).
Submission package RETRO-VASCULAID-PAD clinical DATA study
(s’ouvre dans une nouvelle fenêtre)
Submission package RETRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-PAD clinical DATA study: retrospective data collection of 6000 patients at clinical partners (Annex Clinical Studies).
Standardised set of parameters to evaluate data outcome measurements
(s’ouvre dans une nouvelle fenêtre)
Standardised set of parameters defined to evaluate the data outcome measurements.
Project management handbook, month 1
(s’ouvre dans une nouvelle fenêtre)
Periodic reports with templates (no deliverable) as instructed by the PO.
Submission package PRO-VASCULAID-PAD clinical DATA study
(s’ouvre dans une nouvelle fenêtre)
Submission package PRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-PAD clinical DATA study: prospective data collection of 420 patients (phase I) at clinical partners (Annex Clinical Studies).